Iona Medicines advances the discovery and development of antibody therapeutics for rare and neglected diseases.

We apply a non-traditional sponsor operating model to areas where conventional drug development economics have failed to bring treatments to patients.

We are currently prioritizing antibody therapeutics targeting viral pathogens with pandemic potential, with a particular focus on restarting development programs for candidates that have stalled for operational rather than scientific reasons.